APA (7th ed.) Citation

Murashima, Y., Yamamoto, S., Hirose, T., Kadono, T., Ikeda, G., Ohara, A., . . . Kato, K. (2024). Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma. Journal of Gastrointestinal Cancer, 55(3), 1345-1351. https://doi.org/10.1007/s12029-024-01092-w

Chicago Style (17th ed.) Citation

Murashima, Yuko, et al. "Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma." Journal of Gastrointestinal Cancer 55, no. 3 (2024): 1345-1351. https://doi.org/10.1007/s12029-024-01092-w.

MLA (9th ed.) Citation

Murashima, Yuko, et al. "Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma." Journal of Gastrointestinal Cancer, vol. 55, no. 3, 2024, pp. 1345-1351, https://doi.org/10.1007/s12029-024-01092-w.